CN Unveils Innovative Transload Facility in Flat Rock
FLAT ROCK, Mich., May 14, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) is proud to announce the grand […]
Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health […]
Atlantic American Corporation Reports First Quarter Results for 2024
ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net loss of $2.0 million, or […]
ShoulderUp Technology Acquisition Corp. Announces Postponement of Special Meeting of Stockholders.
Kennesaw, GA, May 14, 2024 (GLOBE NEWSWIRE) — ShoulderUp Technology Acquisition Corp. (“ShoulderUp” or the “Company”) today announced that its […]
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
Additional analyses of data from AURORA, as well as the full adult data set from BEACON Updated data from the […]
Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress
Treatment with AFM28 innate cell engager (ICE®), designed to target CD123-positive cancer cells in patients with acute myeloid leukemia (AML), […]
Dr. Nikolas Tsakos, Founder & CEO of TEN Ltd. Interview Today Live at NYSE – Schwab Network
ATHENS, Greece, May 14, 2024 (GLOBE NEWSWIRE) — TEN, Ltd. (TEN) (NYSE: TNP) (the “Company”) announced today that the Founder […]
Trust Stamp Provides a Business Report and Financial Results for the Three Months Ended March 31, 2024
ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered trust and identity […]
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell […]
Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]
